Saturday, July 11, 2026

pharma · Non-Muscle Invasive Bladder Urothelial Carcinoma · Nasopharyngeal Cancinoma (NPC)

Chongqing Daxin Pharmaceutical

News and analysis for Chongqing Daxin Pharmaceutical on NovaPharmaNews — regulatory, clinical, and market coverage.

Chongqing, CN HQ
5 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Chongqing, CN
Employees
5
Programs
2
Drugs
6
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Chongqing Daxin Pharmaceutical — regulatory, clinical, and market coverage.

News and analysis for Chongqing Daxin Pharmaceutical on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Chongqing Daxin Pharmaceutical yet.

Back to company overview →